HighTower Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $922K | Buy |
14,066
+689
| +5% | +$45.2K | ﹤0.01% | 2062 |
|
2025
Q1 | $944K | Sell |
13,377
-276
| -2% | -$19.5K | ﹤0.01% | 1996 |
|
2024
Q4 | $897K | Buy |
13,653
+261
| +2% | +$17.2K | ﹤0.01% | 2035 |
|
2024
Q3 | $945K | Sell |
13,392
-512
| -4% | -$36.1K | ﹤0.01% | 1957 |
|
2024
Q2 | $922K | Buy |
13,904
+8,210
| +144% | +$544K | ﹤0.01% | 1897 |
|
2024
Q1 | $386K | Sell |
5,694
-144
| -2% | -$9.76K | ﹤0.01% | 2467 |
|
2023
Q4 | $361K | Buy |
5,838
+15
| +0.3% | +$928 | ﹤0.01% | 2557 |
|
2023
Q3 | $343K | Buy |
5,823
+1,557
| +36% | +$91.7K | ﹤0.01% | 2479 |
|
2023
Q2 | $255K | Buy |
4,266
+843
| +25% | +$50.4K | ﹤0.01% | 2663 |
|
2023
Q1 | $202K | Sell |
3,423
-372
| -10% | -$22K | ﹤0.01% | 2731 |
|
2022
Q4 | $235K | Buy |
+3,795
| New | +$235K | ﹤0.01% | 2625 |
|
2019
Q2 | – | Sell |
-4,827
| Closed | -$248K | – | 2297 |
|
2019
Q1 | $248K | Buy |
+4,827
| New | +$248K | ﹤0.01% | 1823 |
|